Cite
Atorvastatin prevents Angiotensin II induced myocardial hypertrophy in vitro via CCAAT/enhancer-binding protein β.
MLA
Chen, Yintao, et al. “Atorvastatin Prevents Angiotensin II Induced Myocardial Hypertrophy in Vitro via CCAAT/Enhancer-Binding Protein β.” Biochemical & Biophysical Research Communications, vol. 486, no. 2, Apr. 2017, pp. 423–30. EBSCOhost, https://doi.org/10.1016/j.bbrc.2017.03.057.
APA
Chen, Y., Yu, S., Zhang, N., Li, Y., Chen, S., Chang, Y., Sun, G., & Sun, Y. (2017). Atorvastatin prevents Angiotensin II induced myocardial hypertrophy in vitro via CCAAT/enhancer-binding protein β. Biochemical & Biophysical Research Communications, 486(2), 423–430. https://doi.org/10.1016/j.bbrc.2017.03.057
Chicago
Chen, Yintao, Shasha Yu, Naijin Zhang, Yuan Li, Shuang Chen, Ye Chang, Guozhe Sun, and Yingxian Sun. 2017. “Atorvastatin Prevents Angiotensin II Induced Myocardial Hypertrophy in Vitro via CCAAT/Enhancer-Binding Protein β.” Biochemical & Biophysical Research Communications 486 (2): 423–30. doi:10.1016/j.bbrc.2017.03.057.